cyclobenzaprine + naproxen

Cyclobenzaprine + naproxen is a combination therapy consisting of two distinct pharmaceutical agents: cyclobenzaprine, a centrally acting skeletal muscle relaxant, and naproxen, a nonsteroidal anti-inflammatory drug (NSAID). Cyclobenzaprine works primarily by reducing tonic somatic motor activity influencing both alpha and gamma motor neurons, thereby alleviating muscle spasm associated with acute musculoskeletal conditions. Naproxen inhibits the enzyme cyclooxygenase (COX), decreasing the formation of prostaglandins involved in pain, inflammation, and fever. This combination is used short-term in the management of acute conditions characterized by muscle spasm, pain, and inflammation, such as acute low back pain or musculoskeletal injuries. There are no known major pharmacokinetic interactions between the two drugs, and their combined use can provide more comprehensive relief than either alone in certain cases. However, side effects—primarily drowsiness (from cyclobenzaprine) and gastrointestinal discomfort or increased risk of GI bleeding (from naproxen)—are more common when combined. The combination should be limited to short, temporary courses (frequently not exceeding 2–3 weeks)[1][2][3][8].